Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 806-509-1 | CAS number: 1393571-42-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The test substance is a skin irritant,but not corrosive based on the outcome of the in vitro EPISKIN test (Harlan 2012h and Harlan 2013e). No eye irritation was found in both an in vitro assay (Harlan 2012i) and an in vivo skin irritation test in rabbits (Harlan 2013f)
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 11-04-2012 to 17-04-2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: study performed according to the guideline and under GLP
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Principles of method if other than guideline:
- exposure period 15 minutes with post-exposure incubation period of 42 hours
- GLP compliance:
- yes (incl. QA statement)
- Details on study design:
- The EpiSKIN assay uses reconstructed human epidermis to assess skin irritation. For the viability test enzymatic conversion of MTT to formazan is used.
In a pre-test direct interaction of the test substance with the detection chemical MTT is assessed.
In the main study triplicate tissues were treated with 30 uL of the test substance during 15 minutes. In addition a negative control (DPBS) and a positive control (5% SDS) were included. After treatment tissues were rinsed, incubated in maintenance fluid for 42 hours at 37 °C and treated with MTT during 3 hours (at 37 °C). After MTT loading a total biopsy of each epidermis (epidermis and collagen) was made, that was suspended in acidified iso-propanol for 3 days and kept in the refrigerator at 1-10 °C. Thereafter the optical density of the extracted MTT solutions was measured at 540 nm. Viability was expressed as percentage MTT conversion versus negative control.
Tissue viability > 50% means non-irritant
Tissue viability ≤ 50% means irritant - Other effects:
- The test substance did not interfere with the reduction of MTT to blue formazan salt.
In the main test after rinsing, the test substance was found to remain on the tissue surface due to the extreme viscosity. - Interpretation of results:
- irritating
- Remarks:
- Migrated information Criteria used for interpretation of results: other: tissue viability > 50%: non-irritant
- Conclusions:
- The test substance is irritant in the EPISKIN reconstructed human epidermal model.
- Executive summary:
In this assay triplicate reconstructed human skin tissues were treated with 30 uL of the test substance during 15 minutes. After treatment tissues were rinsed, kept for 42 hours and treated with MTT. Optical density of extracted MTT solutions was measured at 540 nm. Viability was expressed as percentage MTT conversion versus negative control. The viability was 10.2%, which is indicative for irritant substances.
The test substance is irritant in the EPISKIN reconstructed human epidermal model.
Reference
|
Mean OD540 ± SD |
Relative mean viability ± SD |
Negative control: |
0.883 ± 0.087 |
100 ± 9.8% |
Test substance: |
0.090 ± 0.051 |
10.2 ± 5.8% |
SDS: |
0.053 ± 0.018 |
6.0 ± 2.1% |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15-04-2013 to 25-04-2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: study according to the guidelines under GLP
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion)
- GLP compliance:
- yes (incl. QA statement)
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories UK Ltd., Leicestershire, UK
- Age at study initiation: 12 to 20 weeks
- Weight at study initiation: 2.50 to 2.71 kg
- Housing: individually
- Diet: ad libitum (2930C Teklad Global Rabbit diet supplied by Harlan Laboratories UK Ltd., Oxon)
- Water; ad libitum
- Acclimation period: minimal 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17-23
- Humidity (%): 30-70
- Air changes (per hr): ≥15/hr
- Photoperiod (hrs dark / hrs light): 12/12 - Vehicle:
- unchanged (no vehicle)
- Controls:
- not required
- Amount / concentration applied:
- 0.1 mL applied to the conjunctival sac of the right eye
- Observation period (in vivo):
- 1, 24, 48 and 72 hour observations
- Number of animals or in vitro replicates:
- 2
- Details on study design:
- ANAESTHETICS AND ANALGESICS
– doses and times when topical anaesthetics and systemic analgesics were administered:
systemic: buprenorphine 0.01 mg/kg sc 60 minutes prior to dosing
local: 0.5% tetracaine hydrochloride (2 drops ineach eye) 5 minutes prior to dosing
systemic: buprenorphine 0.01 mg/kg sc and meloxicam 0.5 mg/kg sc 8 hours after dosing
- interaction with test substance: none reported
- inititial pain score: not reported
REMOVAL OF TEST SUBSTANCE
- Washing (if done): none
SCORING SYSTEM: Draize
TOOL USED TO ASSESS SCORE: standard ophthalmoscope (no fluorescein used) - Irritation parameter:
- cornea opacity score
- Basis:
- mean
- Time point:
- other: average 24-72 h
- Score:
- 0
- Max. score:
- 0
- Irritation parameter:
- iris score
- Basis:
- mean
- Time point:
- other: average 24-72 h
- Score:
- 0
- Max. score:
- 0
- Irritation parameter:
- conjunctivae score
- Basis:
- mean
- Time point:
- other: avarage 24-72h
- Score:
- 1
- Max. score:
- 1
- Reversibility:
- fully reversible within: 72 hours
- Irritation parameter:
- chemosis score
- Basis:
- mean
- Time point:
- other: average 24-72 h
- Score:
- 1
- Max. score:
- 1
- Reversibility:
- fully reversible within: 72 hours
- Irritant / corrosive response data:
- not irritant
- Other effects:
- No effects on body weight
- Interpretation of results:
- not irritating
- Remarks:
- Migrated information Criteria used for interpretation of results: expert judgment
- Conclusions:
- The test substance is not irritating to the eyes
- Executive summary:
In an in vivo test two rabbits were treated with the test substance (0.1 mL applied in the conjunctival sac of one eye) after systemic and local analgesia/anaesthesia . No signs of irritatiion except for very slight effects on the conjunctivae after 1, 24 and 48 hours became apparent. After 72 hours no effects were noted. Therefore it is concluded that the test substance is not irritating to the eyes.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Skin irritation/corrosion
In an in vitro assay (EpiSKIN reconstructed human epidermal model) for irritation, triplicate skin tissues were treated with 30 uL of the test substance during 15 minutes. After treatment tissues were rinsed, kept for 42 hours and treated with MTT. Optical density of extracted MTT solutions was measured at 540 nm. The viability was 10.2%, which is indicative for irritant substances (Harlan 2012h).
In the EpiSKIN test for corrosion, duplicate reconstructed human skin tissues were treated with 50 uL of the test substance during 3, 60 and 240 minutes. After treatment tissues were rinsed and incubated with MTT for 3 hours (at room temeprature). Thereafter tissues were allowed to dry, epidermis and collagen were separated, suspended (after vortexing) in isopropanol and kept overnight (all procedures in dark). Optical density of homogene solutions of MTT treated tissues was measured at 540 nm. Viability was expressed as percentage MTT conversion versus negative control. The viability was 68.7 -97.0% for the different exposure times, which is indicative for non-corrosive substances (Harlan 2013e).
Eye irritation
In the SkinEthic test tissues were treated with 30 uL of the test substance during 10 minutes. After treatment tissues (2 per treatment) were rinsed and treated with MTT. Optical density of extracted MTT solutions was measured at 540 nm. The viability was 60.2%, which is indicative for non-irritant substances. As the assay is not formally validated, the results need to be regarded as preliminary (Harlan 2012i).
In an in vivo test two rabbits were treated with the test substance (0.1 mL applied in the conjunctival sac of one eye) after systemic and local analgesia/anaesthesia . No signs of irritatiion except for very slight effects on the conjunctivae after 1, 24 and 48 hours became apparent. After 72 hours no effects were noted. Therefore it is concluded that this test confirms the results of the in vitro assay and the test substance is not irritating to the eyes (Harlan 2013f).
Justification for selection of skin irritation / corrosion endpoint:
study according to the guidelines under GLP with positive result
Justification for selection of eye irritation endpoint:
In view of the negative results in the in vitro eye irritation study and the positive in vitro test for skin irritation, the in vivo test was performed to confirm the negative outcome.
Effects on skin irritation/corrosion: irritating
Justification for classification or non-classification
The substance needs to be classified for skin irritation based on the outcome of the in vitro skin irritation test (H315). The substance is not corrosive (Harlan 2013e). No classification is necessary for eye irritation as both tests available did not show any effects of the test substance on the eye.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.